Deriving cells expressing markers of female germ cells from premature ovarian failure patient-specific induced pluripotent stem cells.
Regen Med
; 12(2): 143-152, 2017 03.
Article
in En
| MEDLINE
| ID: mdl-28244827
AIM: We proposed a two-step protocol for deriving cells expressing markers of female germ cells (FGCs) from premature ovarian failure patient-specific induced pluripotent stem cells (POF-iPSCs). MATERIAL & METHODS: We cultured POF-iPSCs in suspension and pretreated them with TGFß-1 (1 ng/ml) for 2 days and continued with both TGFß-1 and BMP4 (50 ng/ml) for 5 more days. Then changed to media containing retinoic acid (1 µM) and 5% follicular fluid for another 7 days. Expression of markers of different stages of FGCs were detected. RESULTS: c-KIT, STELLA/DPPA3, VASA/DDX4, SCP3, GDF9 and ZP3 were positively detected and statistically significant different when compared with control groups. CONCLUSION: Our in vitro system was beneficial for POF-iPSCs differentiated cells to express STELLA, VASA and SCP3, which were the markers of meiosis initiation of FGCs.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biomarkers
/
Cell Differentiation
/
Primary Ovarian Insufficiency
/
Induced Pluripotent Stem Cells
/
Germ Cells
Limits:
Adult
/
Female
/
Humans
Language:
En
Journal:
Regen Med
Year:
2017
Document type:
Article
Affiliation country:
China
Country of publication:
United kingdom